Literature DB >> 27448483

Influence of sleep disturbances on age at onset and long-term incidence of major cardiovascular events: the MONICA-Brianza and PAMELA cohort studies.

Francesco Gianfagna1, Giovanni Veronesi2, Lorenza Bertù2, Giancarlo Cesana3, Guido Grassi4, Saverio Stranges5, Camilla Callegari6, Marco M Ferrario7.   

Abstract

OBJECTIVE: We examined the prospective associations of sleep disturbances and sleep duration with the long-term incidence of major cardiovascular disease (CVD) events, in a large cohort of Italian adult men.
METHODS: A total of 2277 men aged 35-74 years of age and CVD free at baseline from the MONICA-Brianza and PAMELA population-based cohorts were followed up for a median of 17 years, for first coronary heart disease (CHD) or ischemic stroke events (fatal or nonfatal; n = 293). Sleep disturbances, based on the Jenkins Sleep Questionnaire, were categorized as none/some, moderate, or severe. Sleep durations were ≤6 hours (short), seven to eight hours, and ≥9 hours (long) per night.
RESULTS: At baseline, 855 men (38%) either reported sleep disturbances or were short or long sleepers. The presence of severe sleep disturbances increased the risk of first CVD (hazard ratio [HR] = 1.80, 95% confidence interval [CI] = 1.07-3.03) and CHD events (HR = 1.97, 95% CI = 1.09-3.56), in particular from the age of 48 years onward. In comparison to men sleeping seven to eight hours, long sleepers experienced a higher CVD risk (HR = 1.56, 95% CI = 1.10-2.22), due mainly to ischemic strokes, and starting at older ages (≥60 years). A joint effect between disturbed sleep and short sleep duration on CVD and CHD events was also observed. Adjustments for physical activity and depression did not substantially modify these associations.
CONCLUSION: Severe sleep disturbances and long sleep duration were associated with specific CVD endpoints and age at onset, potentially suggesting distinct underlying mechanisms. A short questionnaire discriminating different levels of sleep disturbances and sleep duration should be routinely adopted in CVD prevention programs to identify men at increased risk for early-onset events.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Coronary artery diseases; Depression; Epidemiology; Sleep disorders; Stroke

Mesh:

Year:  2016        PMID: 27448483     DOI: 10.1016/j.sleep.2016.01.007

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  8 in total

1.  Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study.

Authors:  Marta Ielmini; Ivano Caselli; Francesca Ceccon; Marcello Diurni; Nicola Poloni; Camilla Callegari
Journal:  Psychopharmacol Bull       Date:  2021-11-03

2.  Development and validation of the Maugeri Sleep Quality and Distress Inventory (MaSQuDI-17).

Authors:  Elisa Morrone; Cinzia Sguazzin; Giorgio Bertolotti; Andrea Giordano; Alberto Braghiroli; Gian Luigi Balestroni; Raffaele Manni; Luigi Ferini Strambi; Vincenza Castronovo; Marco Zucconi; Fabrizio De Carli; Eleonora Pinna; Marcella Ottonello; Ines Giorgi; Michele Terzaghi; Sara Marelli; Francesco Fanfulla
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

3.  Restfulness from sleep and subsequent cardiovascular disease in the general population.

Authors:  Hidehiro Kaneko; Hidetaka Itoh; Hiroyuki Kiriyama; Tatsuya Kamon; Katsuhito Fujiu; Kojiro Morita; Nobuaki Michihata; Taisuke Jo; Norifumi Takeda; Hiroyuki Morita; Hideo Yasunaga; Issei Komuro
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

4.  Depressive symptoms and sleep problems as risk factors for heart disease: a prospective community study.

Authors:  S S Deschênes; R J Burns; E Graham; N Schmitz
Journal:  Epidemiol Psychiatr Sci       Date:  2019-08-20       Impact factor: 6.892

5.  Association of sleep-related disorders with cardiovascular disease among adults in the United States: A cross-sectional study based on national health and nutrition examination survey 2005-2008.

Authors:  Kaisaierjiang Kadier; Lian Qin; Aikeliyaer Ainiwaer; Rena Rehemuding; Diliyaer Dilixiati; Yi-Ying Du; Halimulati Maimaiti; Xiang Ma; Yi-Tong Ma
Journal:  Front Cardiovasc Med       Date:  2022-08-04

6.  Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants.

Authors:  Yi-Ming Huang; Wei Xia; Yi-Jun Ge; Jia-Hui Hou; Lan Tan; Wei Xu; Chen-Chen Tan
Journal:  Front Cardiovasc Med       Date:  2022-09-27

7.  Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis.

Authors:  Chun Shing Kwok; Evangelos Kontopantelis; George Kuligowski; Matthew Gray; Alan Muhyaldeen; Christopher P Gale; George M Peat; Jacqueline Cleator; Carolyn Chew-Graham; Yoon Kong Loke; Mamas Andreas Mamas
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

8.  Sleep quality and risk of coronary heart disease - a prospective cohort study from the English longitudinal study of ageing.

Authors:  Chenxi Song; Rui Zhang; Jiaqiang Liao; Rui Fu; Chunyue Wang; Qianqian Liu; Weihua Song; Hongjian Wang; Kefei Dou
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.